Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05010707Phase 2Completed
A Phase 2 trial of estradiol topical in gender dysphoria (GD), sponsored by Washington University School of Medicine. Started Aug 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05010707.